Dr. Hromas Discusses Myeloma and CLL Progress – ASH Annual Meeting 2015

Dr. Hromas was recently interviewed at the ASH (American Society of Hematology) Annual Meeting 2015, discussing the progress in blood cancers, in particular Myeloma and CLL.

“This is an enormously exciting time to be a hematologist, to be a blood doctor. I can’t explain to you how gratifying it is to see that 30 years ago all my patients with Myeolma would pass away, and they would pass away in pain,” Dr. Hromas explains, “now, I haven’t lost anybody in many years because of the new drugs, the exciting new drugs in Multiple Myeolma.”